✦ LIBER ✦

Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs

✍ Scribed by P. M. Mannucci; A. Gringeri; M. Morfini; R. De Biasi; M. C. Tirindelli; G. Tamponi; F. Baudo; V. Carnelli; N. Ciavarella; M. Colombo; A. Zanetti

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 310 KB
Volume: 29
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830290407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and efficacy of a killed

Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children

✍ Richtmann, Rosana; Chaves, Ricardo L.; Mendonça, João S.; Konichi, Selia R.; Mit 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

The objective of this study was to characterize the immune response of children after the use of two different vaccine doses and to evaluate whether vaccination benefits children attending day care centers in areas with high anti-HAV seroprevalence. The study was conducted in a day care center with

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

A study of the antigenicity and immunoge

A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies

✍ Waters, J. A.; Bailey, C.; Love, C.; Thomas, H. C. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

The successful prevention of infection with hepatitis B virus (HBV) has been achieved by vaccination with purified hepatitis B surface antigen (HBsAg). The ability of a novel synthetic HBV envelope antigen vaccine (Hep B-3, Hepa-gene™; Medeva), which contains part of the pre-S1 and the complete pre-

A two dose combined hepatitis A and B va

A two dose combined hepatitis A and B vaccine in Chinese youngsters

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

This open, randomized study was conducted in healthy Chinese youngsters, aged between 10 and 19 years to compare the reactogenicity and immunogenicity of two vaccines: the combined vaccine against hepatitis A and B was administered in a two-dose schedule with the profile of the corresponding monoval

Immunogenicity and antitumor activity of

Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine

✍ John Samuel; Wladyslaw A. Budzynski; Mark A. Reddish; Lei Ding; Gabrielle L. Zim 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 1 views

A human MUC1-transfected mouse mammary adenocarcinoma cell line (GZHI) was used to develop both subcutaneous and intravenous tumor models. A vaccine formulation comprised of a 24 mer (human MUC1) synthetic peptide encapsulated with monophosphoryl lipid A adjuvant (MPLA) in multilamellar liposomes wa

A new cluster of hepatitis A infection i

A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool

✍ Chudy, Michael; Budek, Irmhild; Keller-Stanislawski, Brigitte; McCaustland, Kare 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Recently, several clusters of hepatitis A have been observed among hemophiliacs linked to factor VIII concentrates treated for virus inactivation solely with the solvent/detergent (S/D) method, a procedure that does not affect nonenveloped viruses such as the hepatitis A virus (HAV). A new outbreak